rrd178067_201213.html

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GVAf+cXZ2xmPaKv8C3xf9gouRfprwJDJNvHLRBVxBSISjP9PVPy5u0fWAfC9zo/v BrYRAVE/x00UMs7+KV4ZqA== 0001181431-08-018662.txt : 20080313 0001181431-08-018662.hdr.sgml : 20080313 20080313185616 ACCESSION NUMBER: 0001181431-08-018662 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080225 FILED AS OF DATE: 20080313 DATE AS OF CHANGE: 20080313 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAUSCHER STEVEN M CENTRAL INDEX KEY: 0001166683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 08687358 MAIL ADDRESS: STREET 1: C/O GNOME THERAPEUTICS CORP STREET 2: 100 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02453 4 1 rrd199456.xml FORM 4 X0202 4 2008-02-25 0 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001166683 RAUSCHER STEVEN M 1000 WINTER ST. SUITE 2200 WALTHAM MA 02451 1 1 0 0 CEO and President Common Stock 2008-02-25 4 A 0 18147 0.00 A 67210 D Stock Option (right to purchase) 2.16 2008-02-25 4 A 0 45303 0.00 A 2018-02-24 Common Stock 45303 45303 D Restricted Shares issued under the Company's 2001 Incentive Plan; 50% vest on November 30, 2008 and 50% vest on November 30, 2009. Issued under the Company's 2001 Incentive Plan; 25% vest immediately and the remaining 75% vest quarterly in equal installments over 2 years from the date of grant. Stanley F. Chalvire, Esq., Corporate Attorney - Power of Attorney 2008-03-13 EX-99. 2 rrd178067_201213.htm POWER OF ATTORNEY rrd178067_201213.html

					POWER OF ATTORNEY



       I hereby constitute and appoint each of Robert E. Farrell, Jr. and Stanley F. Chalvire, Esq.,
signing singly, my true and lawful attorney-in-fact to:

(1)	execute for and on my behalf, in my capacity as a officer and/or director of Oscient
Pharmaceuticals Corporation (the "Company"), Forms 3, 4 and 5 in accordance with
Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)	do and perform any and all acts for and on my behalf that may be necessary or desirable
to complete and execute any such Form 3, 4 or 5 and timely file such form with the
United States Securities and Exchange Commission and any stock exchange or similar
authority; and

(3)	take any other action of any type whatsoever in connection with the foregoing which, in
the opinion of such attorney-in-fact, may be to my benefit, in my best interest, or that I
am legally required to do, it being understood that the documents executed by such
attorney-in-fact's discretion.

       I hereby grant to each such attorney-in-fact full power and authority to do and perform
any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and purposes as I might or
could do if personally present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the rights and powers
herein granted.  I acknowledge that the attorneys-in-fact, in serving in such capacity at my
request, are not assuming, nor is the Company assuming, any of my responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

       This Power of Attorney hereby supersedes and revokes any and all Powers of Attorney
previously granted for the purpose of executing for and on my behalf, Company Forms 3, 4 and 5
in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder.

	This Power of Attorney shall remain in full force and effect until I am no longer required
to file Forms 3, 4 and 5 with respect to my holdings of and transactions in Company securities,
unless I earlier revoke it in a signed writing delivered to the attorneys-in-fact.

	IN WITNESS WHEREOF, I have caused this Power of Attorney to be executed as of this
20th day of September 2007.



					_/s/__________________________________
					Steven M. Rauscher
					President, Chief Executive Officer, and Director

-----END PRIVACY-ENHANCED MESSAGE-----